A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer

被引：0
|
作者：
Takeyoshi, I.
Makita, F.
Tanahashi, Y.
Iwazaki, S.
Nakamura, S.
Ishikawa, H.
Ogawa, T.
Ohya, T.
Kawate, S.
Horiguchi, J.
Morishita, Y.
机构：
[1] Gunma Univ, Grad Sch Med, Gunma, Japan
[2] Nishi Gunma Hosp, Shibukawa, Japan
[3] Shibukawa Gen Hosp, Shibukawa, Japan
[4] Tatebayashi Kosei Hosp, Tatebayashi, Japan
[5] Takasaki Hosp, Takasaki, Gunma, Japan
[6] Fujiyoshida Hosp, Fujiyoshida, Yamanashi, Japan
[7] Maebashi Red Cross Hosp, Maebashi, Gunma, Japan
[8] Ojiya Gen Hosp, Ojiya, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4593
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer.
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Iwazaki, S
    Nakamura, S
    Ogawa, T
    Ishikawa, H
    Ohya, T
    Kawate, S
    Morishita, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 328S - 328S
  • [2] A Phase II Study of Weekly Paclitaxel and Doxifluridine Combination Chemotherapy for Advanced/Recurrent Gastric Cancer
    Takeyoshi, Izumi
    Makita, Fuji
    Tanahashi, Yoshifumi
    Iwazaki, Shigeru
    Ogawa, Tetsushi
    Tomizawa, Naoki
    Nakamura, Seiji
    Ishikawa, Hitoshi
    Ohya, Toshihiro
    Kakinuma, Shinichi
    Nakagami, Katsunao
    Sato, Yoshihiro
    Koyano, Tetsuya
    Roppongi, Takashi
    Izumi, Masaru
    Kobayashi, Junya
    Kawate, Susumu
    Sunose, Yutaka
    Kobayashi, Mitsunobu
    Yamada, Tatsuya
    Sakamoto, Ichiro
    ANTICANCER RESEARCH, 2011, 31 (01) : 287 - 291
  • [3] A combination chemotherapy of weekly paclitaxel and doxifluridine (5′-DFUR: an intermediate metabolite of capecitabine) in patients with unresectable or recurrent gastric cancer in an outpatient setting. Final results of a multicenter phase II trial
    Yoshino, S.
    Nishimura, T.
    Hazama, S.
    Oka, M.
    Ozasa, H.
    Shimizu, R.
    Furuya, T.
    Fukuda, S.
    Satoh, T.
    Hara, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer
    Takaki Yoshikawa
    Akira Tsuburaya
    Ken Shimada
    Atsushi Sato
    Makoto Takahashi
    Wasaburo Koizumi
    Yasuo Yoshizawa
    Kazuhito Nabeshima
    Masayuki Kimura
    Kiyoshi Hataya
    Osamu Kobayashi
    Gastric Cancer, 2009, 12 : 212 - 218
  • [5] A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer
    Yoshikawa, Takaki
    Tsuburaya, Akira
    Shimada, Ken
    Sato, Atsushi
    Takahashi, Makoto
    Koizumi, Wasaburo
    Yoshizawa, Yasuo
    Nabeshima, Kazuhito
    Kimura, Masayuki
    Hataya, Kiyoshi
    Kobayashi, Osamu
    GASTRIC CANCER, 2009, 12 (04) : 212 - 218
  • [6] A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Yokomori, T
    Iwazaki, S
    Kawashima, Y
    Iwanami, K
    Yamada, T
    Kawate, S
    Hamada, K
    Sunose, Y
    Yoshida, M
    Horiguchi, J
    Iesato, H
    Kobayashi, M
    Morishita, Y
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1291 - 1296
  • [7] Phase II Study of Weekly Paclitaxel and Cisplatin Combination Therapy for Advanced or Recurrent Gastric Cancer
    Nagata, Naoki
    Kimura, Masayuki
    Hirabayashi, Naoki
    Tuburaya, Ahira
    Murata, Teruo
    Kondo, Ken
    Fukuda, Yasuhiko
    Kobayashi, Michiya
    Miyashita, Yumi
    Nakao, Akimasa
    Sahamoto, Junichi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1846 - 1850
  • [8] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    Kang, H. J.
    Chang, H. M.
    Kim, T. W.
    Ryu, M-H
    Sohn, H-J
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Lee, J-S
    Kang, Y-K
    BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 316 - 322
  • [9] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    H J Kang
    H M Chang
    T W Kim
    M-H Ryu
    H-J Sohn
    J H Yook
    S T Oh
    B S Kim
    J-S Lee
    Y-K Kang
    British Journal of Cancer, 2008, 98 : 316 - 322
  • [10] Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
    Jong Gwang Kim
    Sang Kyun Sohn
    Hong Suk Song
    Ki-Young Kwon
    Young Rok Do
    Kyung Hee Lee
    Myung Soo Hyun
    Hun Mo Ryoo
    Sung Hwa Bae
    Keon Uk Park
    Jin Ho Baek
    Won Sik Lee
    Joo Seop Chung
    Goon Jae Cho
    Chang-Hak Sohn
    Jung Soon Jang
    Ho Young Chung
    Wansik Yu
    Cancer Chemotherapy and Pharmacology, 2007, 60
12345